Literature DB >> 10194457

Chagas' disease and the autoimmunity hypothesis.

F Kierszenbaum1.   

Abstract

The notion that the pathology of Chagas' disease has an autoimmune component was initially based on the finding of circulating antibodies binding heart tissue antigens in patients and mice chronically infected with Trypanosoma cruzi. Later, T lymphocytes reactive with heart or nerve tissue antigens were found in chagasic mice and patients, extending the concept to include cell-mediated immunity. However, there is disagreement about whether the observed immunologic autoreactivities are triggered by T. cruzi epitopes and then affect host tissue antigens by virtue of molecular mimicry or are elicited by host antigens exposed to lymphocytes after tissue damage caused by the parasite. There is also disagreement about the relevance of immunologic autoreactivities to the pathogenesis of Chagas' disease because of the lack of reproducibility of some key reports supporting the autoimmunity hypothesis, conflicting data from independent laboratories, conclusions invalidated by advances in our understanding of the immunologic mechanisms underlying cell lysis, and, last but not least, a lack of direct, incontrovertible evidence that cross-reacting antibodies or autoreactive cells mediate the typical pathologic changes associated with human Chagas' disease. The data and views backing and questioning the autoimmunity hypothesis for Chagas' disease are summarized in this review.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194457      PMCID: PMC88915          DOI: 10.1128/CMR.12.2.210

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  123 in total

Review 1.  Studies of the coronary circulation in Chagas' heart disease.

Authors:  J A Marin-Neto; M V Simões; E M Ayres-Neto; J L Attab-Santos; L Gallo; D S Amorim; B C Maciel
Journal:  Sao Paulo Med J       Date:  1995 Mar-Apr       Impact factor: 1.044

2.  Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications.

Authors:  J C Goin; C P Leiros; E Borda; L Sterin-Borda
Journal:  FASEB J       Date:  1997-01       Impact factor: 5.191

3.  Involvement of laminin and its receptor in abrogation of heart graft rejection by autoreactive T cells from Trypanosoma cruzi-infected mice.

Authors:  S D Silva-Barbosa; V Cotta-de-Almeida; I Riederer; J De Meis; M Dardenne; A Bonomo; W Savino
Journal:  J Immunol       Date:  1997-07-15       Impact factor: 5.422

4.  Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease.

Authors:  R Elies; I Ferrari; G Wallukat; D Lebesgue; P Chiale; M Elizari; M Rosenbaum; J Hoebeke; M J Levin
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

5.  Cardiac myosin-induced myocarditis. Heart autoantibodies are not involved in the induction of the disease.

Authors:  N Neu; B Ploier; C Ofner
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

6.  Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.

Authors:  L X Fu; Y Magnusson; C H Bergh; J A Liljeqvist; F Waagstein; A Hjalmarson; J Hoebeke
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

7.  Role of inflammatory cells in Chagas' disease. II. Interactions of mouse macrophages and human monocytes with intracellular forms of Trypanosoma cruzi: uptake and mechanism of destruction.

Authors:  F Villalta; F Kierszenbaum
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

8.  Chagas' disease cardioneuropathy: association of anti-Trypanosoma cruzi and anti-sciatic nerve antibodies.

Authors:  S Gea; P Ordonez; F Cerban; D Iosa; C Chizzolini; E Vottero-Cima
Journal:  Am J Trop Med Hyg       Date:  1993-11       Impact factor: 2.345

9.  Heterophil nature of EVI antibody in Trypanosoma cruzi infection.

Authors:  E L Khoury; C Diez; P M Cossio; R M Arana
Journal:  Clin Immunol Immunopathol       Date:  1983-05

10.  Do self-heart-reactive T cells expand in Trypanosoma cruzi-immune hosts?

Authors:  C R Gattass; M T Lima; A F Nóbrega; M A Barcinski; G A Dos Reis
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

View more
  33 in total

Review 1.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 2.  The immunology of parasite infections in immunocompromised hosts.

Authors:  T Evering; L M Weiss
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

3.  Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.

Authors:  Simone Garcia; Carolina O Ramos; Juliana F V Senra; Fabio Vilas-Boas; Maurício M Rodrigues; Antonio C Campos-de-Carvalho; Ricardo Ribeiro-Dos-Santos; Milena B P Soares
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  The beta1 adrenergic effects of antibodies against the C-terminal end of the ribosomal P2beta protein of Trypanosoma cruzi associate with a specific pattern of epitope recognition.

Authors:  P Lopez Bergami; K A Gómez; G V Levy; V Grippo; A Baldi; M J Levin
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 5.  Advances and challenges towards a vaccine against Chagas disease.

Authors:  Israel Quijano-Hernandez; Eric Dumonteil
Journal:  Hum Vaccin       Date:  2011-11-01

6.  TNF microsatellite alleles in Brazilian Chagasic patients.

Authors:  Viriato Campelo; Roberto O Dantas; Renata T Simões; Celso T Mendes-Junior; Sandra M B Sousa; Aguinaldo L Simões; Eduardo A Donadi
Journal:  Dig Dis Sci       Date:  2007-08-23       Impact factor: 3.199

7.  Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice.

Authors:  Eric Dumonteil; Javier Escobedo-Ortegon; Norma Reyes-Rodriguez; Arletty Arjona-Torres; Maria Jesus Ramirez-Sierra
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Modulation of autoimmunity by treatment of an infectious disease.

Authors:  Kenneth V Hyland; Juan S Leon; Melvin D Daniels; Nick Giafis; LaKitta M Woods; Thomas J Bahk; Kegiang Wang; David M Engman
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

9.  Antigenicity of Leishmania braziliensis histone H1 during cutaneous leishmaniasis: localization of antigenic determinants.

Authors:  Emma Carmelo; Enrique Martínez; Ana Cristina González; José Enrique Piñero; Manuel E Patarroyo; Antonio Del Castillo; Basilio Valladares
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

10.  Changes in cell migration-related molecules expressed by thymic microenvironment during experimental Plasmodium berghei infection: consequences on thymocyte development.

Authors:  Jacy Gameiro; Patrícia R A Nagib; Carolina F Andrade; Déa M S Villa-Verde; Suse D Silva-Barbosa; Wilson Savino; Fábio T M Costa; Liana Verinaud
Journal:  Immunology       Date:  2009-09-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.